Quick Answer
NeuroPace Inc reported Operating Income Loss of -$16.34 million for the year ending 2025.
- NeuroPace Inc showed an increase of +24.6% in Operating Income Loss from 2024 to 2025.
- This data is from NeuroPace Inc's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), NeuroPace Inc's Operating Income Loss has declined by 25.2%.
- Historical annual values: Fiscal year 2025: -$16.34 million | Fiscal year 2024: -$21.67 million | Fiscal year 2023: -$27.17 million | Fiscal year 2022: -$40.79 million | Fiscal year 2021: -$23.74 million | Fiscal year 2020: -$13.05 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: